Skip to main content
. 2022 Nov 22;9(12):ofac632. doi: 10.1093/ofid/ofac632

Figure 2.

Figure 2.

Hazard ratios of treatment effects per treatment group. A, Patients admitted directly to the ward. B, Patients admitted directly to the ICU. Remdesivir and SARS-CoV-2-neutralizing monoclonal antibodies were not analyzed given the small sample size. Abbreviations: ICU, intensive care unit; IL, interleukin; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.